Geneos Wealth Management’s Invesco S&P MidCap Low Volatility ETF XMLV Stock Holding History

Geneos Wealth Management’s Portfolio XMLV Stock Details XMLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.2K	Hold	531	–	–	﹤0.01%	1609
2026 Q1	$33.4K	Hold	531	–	–	﹤0.01%	1585
2025 Q4	$33.1K	Hold	531	–	–	﹤0.01%	1550
2025 Q3	$33.8K	Hold	531	–	–	﹤0.01%	1523
2025 Q2	$32.7K	Sell	531 -97	-15%	-$5.89K	﹤0.01%	1785
2025 Q1	$38.8K	Buy	628 +451	+255%	+$27.7K	﹤0.01%	1625
2024 Q4	$10.8K	Sell	177 -200	-53%	-$12.5K	﹤0.01%	2025
2024 Q3	$23K	Sell	377 -250	-40%	-$14.6K	﹤0.01%	1512
2024 Q2	$34.6K	Hold	627	–	–	﹤0.01%	1196
2024 Q1	$35.4K	Sell	627 -351	-36%	-$18.9K	﹤0.01%	1185
2023 Q4	$52K	Sell	978 -35	-3%	-$1.76K	﹤0.01%	1046
2023 Q3	$49.8K	Hold	1,013	–	–	﹤0.01%	1079
2023 Q2	$52.4K	Sell	1,013 -250	-20%	-$12.8K	﹤0.01%	1067
2023 Q1	$66.2K	Buy	1,263 +144	+13%	+$7.79K	﹤0.01%	984
2022 Q4	$59.9K	Buy	1,119 +247	+28%	+$13K	﹤0.01%	985
2022 Q3	$41K	Sell	872 -1,385	-61%	-$73.1K	﹤0.01%	1089
2022 Q2	$118K	Hold	2,257	–	–	0.01%	954
2022 Q1	$125K	Sell	2,257 -20,362	-90%	-$1.12M	0.01%	999
2021 Q4	$1.32M	Buy	22,619 +20,406	+922%	+$1.14M	0.05%	329
2021 Q3	$117K	Sell	2,213 -224	-9%	-$12.2K	﹤0.01%	1105
2021 Q2	$131K	Sell	2,437 -401	-14%	-$21.7K	0.01%	1051
2021 Q1	$153K	Sell	2,838 -83	-3%	-$4.17K	﹤0.01%	1093
2020 Q4	$135K	Sell	2,921 -1,870	-39%	-$84.3K	0.01%	1001
2020 Q3	$197K	Sell	4,791 -3,477	-42%	-$148K	0.01%	693
2020 Q2	$331K	Sell	8,268 -3,881	-32%	-$160K	0.02%	517
2020 Q1	$476K	Sell	12,149 -125	-1%	-$6.21K	0.03%	383
2019 Q4	$657K	Buy	12,274 +2,109	+21%	+$112K	0.04%	386
2019 Q3	$533K	Buy	10,165 +2,473	+32%	+$128K	0.03%	395
2019 Q2	$394K	Buy	7,692 +652	+9%	+$33.1K	0.02%	477
2019 Q1	$349K	Buy	7,040 +2,407	+52%	+$116K	0.02%	495
2018 Q4	$203K	Sell	4,633 -220	-5%	-$10.3K	0.02%	600
2018 Q3	$235K	Sell	4,853 -119	-2%	-$5.76K	0.02%	584
2018 Q2	$233K	Buy	+4,972	New	+$228K	0.02%	531

Other funds holding XMLV

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

Dorval Corp Maple Grove, Minnesota $347M AUM 9.29% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geneos Wealth Management's XMLV Position: Q2 2026 in Review

Geneos Wealth Management held its Invesco S&P MidCap Low Volatility ETF (XMLV) position steady in Q2 2026 at 531 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Geneos Wealth Management first reported a position in XMLV in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.32M in Q4 2021. 189 funds tracked by Wall St. Rank hold XMLV as of Q2 2026.

Geneos Wealth Management held 531 shares of Invesco S&P MidCap Low Volatility ETF worth $35.2K as of Q2 2026.
Geneos Wealth Management left its Invesco S&P MidCap Low Volatility ETF share count unchanged in Q2 2026.
Invesco S&P MidCap Low Volatility ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1609 holding.
Geneos Wealth Management first reported a position in Invesco S&P MidCap Low Volatility ETF in Q2 2018 and has held it in 33 quarters since.
Geneos Wealth Management's Invesco S&P MidCap Low Volatility ETF position peaked at $1.32M in Q4 2021.
189 funds tracked by Wall St. Rank held Invesco S&P MidCap Low Volatility ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.